GATC Subsidiary LifeCodexx Appoints Head of Commercial Operations
Former Brahms sales manager boosts LifeCodexx team
“Now that the development of our first test for non-invasive pre-natal diagnostics using Next Generation Sequencing technologies is entering its final phase, we are delighted to be joined by Dr. Burow, an experienced sales expert in the field of prenatal diagnostics. Dr. Burow will energetically assist us to quickly and efficiently establish strategic access to various European key markets,” said Dr. Michael Lutz, CEO of LifeCodexx AG.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.